R. Delva

5.7k citations
99 papers · 2.5k · 1 hit paper · h-index 21

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Prostate Cancer Treatment and Research
    • Renal cell carcinoma treatment
    • Prostate Cancer Diagnosis and Treatment

Papers in

R. Delva

96 papers receiving 2.5k citations

R. Delva's Hit Papers

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial 2015 · 315 citations
3150+3+7Years since publication100200300

Peers

R. Delva
Comparison fields: 5 of 99
  • Oncology 1.3k
  • Pulmonary and Respiratory Medicine 1.3k
  • Cancer Research 538
  • Reproductive Medicine 160
  • Hematology 196
Replace Roberto Petrioli with:
Roberto Petrioli Italy
Giacomo Cartenì Italy
Stephen Shibata United States
Pablo Maroto Spain
P. Fargeot France
Hideyuki Ishida Japan
Luigi Manzione Italy
Stéphane Culine France
Ingrid M.E. Desar Netherlands
Lindsey Gumbrell United Kingdom
R. Delva relative to Roberto Petrioli Italy Roberto Petrioli's profile →
Citations per field
00.5×1.5×2.1×
Roberto Petrioli · 1×
Citations per year

Countries citing papers authored by R. Delva

Since Specialization
Citations

This map shows the geographic impact of R. Delva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Delva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Delva more than expected).

Fields of papers citing papers by R. Delva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Delva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Delva. The network helps show where R. Delva may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Delva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Delva Line = papers co-authored together R. Delva links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015315
2 2004259
3 2008245
4 1996180
5 2011172
6 1999167
7 2007135
8 200871
9
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
199770
10 200859
11 201357
12 200652
13 201247
14 199942
15 201440
16 200539
17 201038
18 201133
19 200631
20 201527

About R. Delva

R. Delva is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 99 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (32 papers), Prostate Cancer Treatment and Research (28 papers), Renal cell carcinoma treatment (17 papers), Testicular diseases and treatments (13 papers), Cancer, Lipids, and Metabolism (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroblastoma Research and Treatments (9 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (538 citations), Reproductive Medicine (160 citations) and Hematology (196 citations). R. Delva has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Érick Gamelin, M. Boisdron‐Celle, Alain Morel, Christine Chevreau, Véronique Guerin‐Meyer, Norbert Ifrah, Gwénaëlle Gravis, Alain Lortholary, Sylvie Négrier and F Larra. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact